SEC Form 4 · accession 0001209191-17-054170

PURE BIOSCIENCE, INC. · PURE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Sep 25, 2017

Accepted (ET)

Sep 27, 2017 · 6:14 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001006028

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Sep 25, 2017	M	9,066	$0.60	A	181,732	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Warrant^F1	$0.75	Sep 25, 2017	D	9,066	D	Aug 1, 2014	Aug 1, 2019	Common Stock	9,066	0	D
Warrant^F1	$0.60	Sep 25, 2017	A	9,066	A	Aug 1, 2014	Sep 25, 2017	Common Stock	9,066	9,066	D
Warrant^F2	$0.60	Sep 25, 2017	M	9,066	D	Aug 1, 2014	Sep 25, 2017	Common Stock	9,066	0	D

F1On September 25, 2017, the Issuer completed the initial closing of a tender offer in which the Issuer offered to amend the terms of the outstanding warrants the Issuer issued to investors participating in private placement financings the Issuer completed on August 29, 2014 (the "2014 Warrants"), on November 23, 2015 (the "2015 Warrants") and on January 23, 2017 (the "2017 Warrants"). As part of the tender offer and in order to raise funds to support its continued operations, the Issuer offered to reduce the respective exercise prices of the 2014, 2015 and 2017 Warrants if the holders agreed to exercise their Warrants in cash by September 25, 2017. The Reporting Person holds a 2014 Warrant and elected to participate in the Issuer's tender offer. As a result, the exercise price and the expiration date, among other terms, of the 2014 Warrant held by the Reporting Person were amended.
F2In accordance with the terms of the Issuer's tender offer, the Reporting Person exercised his 2014 Warrant in full and in cash on September 25, 2017.